Karyopharm Therapeutics Inc. (KPTI)股价已触及新的52周低点，交易价格为5.87美元，这家生物制药公司正面临严峻的市场环境。根据 InvestingPro 数据显示，该公司背负着2.68亿美元的重大债务，且债务资本比率高达0.84。最新股价水平反映出与此前相比的显著下跌，该股票一年来暴跌70.12%。公司的财务健康评分为1.82（被 InvestingPro 评为 ...

Piper Sandler analyst Edward Tenthoff maintained a Buy rating on Karyopharm Therapeutics (KPTI – Research Report) today and set a price target ...

Piper Sandler lowered the firm’s price target on Karyopharm (KPTI) to split-adjusted $15 from $75 and keeps an Overweight rating on the shares ...

$KPTI insiders have traded $KPTI stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.

Karyopharm Therapeutics (KPTI) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.36 per share a year ago.

加拿大皇家银行：重申Karyopharm Therapeutics(KPTI.US)评级，由优于大市调整至优于大市评级, 目标价由3.00美元调整至3.00美元。 Karyopharm Therapeutics（KPTI.US ...

Michael Mano, the SVP of $KPTI, sold 2,793 shares of the company on 03-04-2025 for an estimated $17,567. We received data on the trade from a recent SEC filing. This ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Good morning. My name is Joelle, and I will be your conference operator today. At this time, I would like to welcome everyone to the Karyopharm Therapeutics fourth quarter and full year 2024 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Free Report) crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $11.04 and traded as low as ...